Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2013 by Uppsala University researchers and Flerie Invest, Empros Pharma is developing EMP16, a pharmaceutical weight management treatment expected to launch in 2027.

List your booth number for exhibitions, ask us